about
sameAs
Atezolizumab Trial in Endometrial Cancer - AtTEndAzacitidine in Treating Patients With Newly Diagnosed Previously Untreated or Secondary Acute Myeloid Leukemia Who Are Unsuitable For Intensive ChemotherapyStudy of CB-103 in Adult Patients With Advanced or Metastatic Solid Tumours and Haematological MalignanciesStudy of Bone Mineral Density in Women With Breast Cancer Treated With Triptorelin and Tamoxifen or Exemestane on Protocol IBCSG 25-02
P6153
Q38304604-85FBEC87-9800-470E-AEA6-D1FDCFA49ADFQ40033742-25D80C0E-1B46-43EB-917A-004FEB70D5DDQ40033742-674048C0-AF1E-4A88-8702-5A6445A1E40EQ40033742-998721C5-53EC-4FEC-9C07-12C105966E84Q40033742-C7B79527-0586-446C-8C06-0904430BADA4Q56261485-0C67A341-DABD-4156-9CCF-0D10D2CD43C5Q56855072-85192C6F-36AA-4CA5-BB88-2B254DD45BE6Q57013374-16664400-3CBC-42C9-9671-8A561482A671Q57013374-B9BB64E3-1D9A-42B5-A3EB-01CA9EA64462Q58375565-92B55FAB-40CC-4D4D-8438-9BB9E11D742EQ58882639-6DB61ADD-CFCF-4760-BB49-EBB5979F221BQ58882639-D1513EA5-6E7D-44C0-A3E8-F6D274AA5817Q59159772-C8A41F1D-0408-4EA1-A82C-7FF3ED2E095AQ59662159-F5EC1B4A-5CB4-4D8F-A1DD-B1759F45894FQ61478774-BE9A06C5-4E5B-4FDA-85E4-D28B112CFE62Q63499939-3B853FC1-2353-4459-A69A-2EF84542C459Q63889008-26CC326E-EC3F-43CB-A074-F5A483C830E6Q63889008-B8969B1B-A29D-436B-8570-53103F30194FQ85306779-D90F7DA6-B0F4-4CE8-9DBA-AA1B7D85292CQ87422623-6EC0E88F-0F00-4995-AE0B-38247CAFA6B4
P108
description
facility in Bellinzona, Switzerland
@en
organisatie uit Zwitserland
@nl
schweizer Organisation
@de
منظمة في بيلينزونا، سويسرا
@ar
name
IOSI
@fr
Istituto Oncologico della Svizzera Italiana
@en
type
label
IOSI
@fr
Istituto Oncologico della Svizzera Italiana
@en
altLabel
IOSI
@en
Institute of Oncology Research
@en
Oncology Institute of Southern Switzerland
@en
prefLabel
IOSI
@fr
Istituto Oncologico della Svizzera Italiana
@en
P131
P17
P213
0000 0004 0509 2987
P2427
grid.419922.5
P3500
P571
1993-01-01T00:00:00Z
P625
Point (8.792235 46.169665)